Brachyury regulates proliferation of cancer cells via a p27Kip1-dependent pathway

Research output: Contribution to journalArticlepeer-review

Electronic versions

Documents

  • 31065

    2.75 MB, PDF document

DOI

  • R.J. Mcfarlane
  • S.W. Gollins
  • J. Wakeman
  • J. Jezkova
  • J.S. Williams
  • F. Jones-Hutchins
  • S.J. Sammut
  • S. Gollins
  • I. Cree
  • S. Coupland
  • R.J. McFarlane
  • J.A. Wakeman
The T-box transcription factor Brachyury is expressed in a number of tumour types and has been demonstrated to have cancer inducing properties. To date, it has been linked to cancer associated induction of epithelial to mesenchymal transition, tumour metastasis and expression of markers for cancer stem-like cells. Taken together, these findings indicate that Brachyury plays an important role in the progression of cancer, although the mechanism through which it functions is poorly understood. Here we show that Brachyury regulates the potential of Brachyurypositive colorectal cancer cells to proliferate and reduced levels of Brachyury result in inhibition of proliferation, with features consistent with the cells entering a quiescentlike state. This inhibition of proliferation is dependent upon p27Kip1 demonstrating that Brachyury acts to modulate cellular proliferative fate in colorectal cancer cells in a p27Kip1-dependent manner. Analysis of patient derived colorectal tumours reveals a heterogeneous localisation of Brachyury (in the nucleolus, nucleus and cytoplasm) indicating the potential complexity of the regulatory role of Brachyury in solid colorectal tumours.
Original languageEnglish
Pages (from-to)3813-3822
JournalOncotarget
Volume5
Issue number11
DOIs
Publication statusPublished - 21 May 2014

Total downloads

No data available
View graph of relations